Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. (Q46569225)

23 December 2017

title

Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. (English)

1 reference

23 December 2017

Kaposi's sarcoma-associated herpesvirus

0 references

0 references

0 references

0 references

object named as

human herpesvirus 8

1 reference

Zehava Grossman

1

1 reference

23 December 2017

Jose Iscovich

2

1 reference

23 December 2017

Fidi Schwartz

3

1 reference

23 December 2017

Esther Azizi

4

1 reference

23 December 2017

Avraham Klepfish

5

1 reference

23 December 2017

Ami Schattner

6

1 reference

23 December 2017

Ronit Sarid

7

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

23 December 2017

published in

Mayo Clin Proc

1 reference

23 December 2017

volume

77

1 reference

23 December 2017

issue

9

1 reference

23 December 2017

page(s)

905-909

1 reference

23 December 2017

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Comparison of the distribution of non-AIDS Kaposi's sarcoma and non-Hodgkin's lymphoma in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Sexual transmission and the natural history of human herpesvirus 8 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Dermatology in southwestern Ethiopia: rationale for a community approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(11)62256-8

1 reference

23 December 2017

PubMed ID

12233922

1 reference

23 December 2017